Results revealed that lower SVIP mRNA expression levels were associated with a worse prognosis of overall survival (OS) (HR = 0.74, p = 0.026) (Figure 3D) and distant metastasis-free survival (DMFS) (HR = 0.61, p = 0.00026) (Figure 3E) in breast cancer. This evidence concerns the gene SVIP and breast carcinoma.